ArticleFrontiers in molecular biosciences2025
Bioenergetic and immunological characterization of cryopreserved peripheral blood mononuclear cells (PBMCs) isolated from blood and buffy coat.
Article in Frontiers in molecular biosciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Mitochondrial dysfunction (MD) and inflammaging are hallmarks of non-communicable diseases and play a pivotal role in the ageing process. Determination of mitochondrial function (MF) in Peripheral Blood Mononuclear Cells (PBMCs) represents a minimally invasive method for assessing the pathophysiological state. However, the necessity to measure the cells in a fresh state is a challenge especially in multicenter investigational studies. Therefore, we investigated the mitochondrial and immunological properties of cryopreserved PBMC isolated from whole blood and buffy coats over a storage period of 6 months to establish a procedure to assess MD in frozen samples. Methods: PBMCs were isolated from whole blood and buffy coats using gradient density centrifugation and cryopreserved with fetal bovine serum and dimethyl sulfoxide as antifreeze agents in liquid nitrogen. To identify potential differences between cryopreserved and freshly isolated cells, we investigated cell count and viability, mitochondrial respiration, adenosine triphosphate production, and citrate synthase activity in PBMCs during 6 months of storing. Cell composition was determined using flow cytometry. The immune status was assessed by determining the cytokines IL-6, IL-10, and TNF-α after phytohemagglutinin stimulation using time-resolved fluorescence (HTRF). Results: After cryopreservation and storage of PBMCs isolated from whole blood or buffy coats, their bioenergetic function is preserved for at least 6 months: No statistically significant differences in the parameters CS, ATP, and the complexes of the respiratory chain were observed at any measurement time point. However, fluorescence-activated cell sorting analysis reveals that the number of apoptotic cells increased after 1 month of cryopreservation. After 3 months of cryopreservation, phytohemagglutinin-activated cytokines IL-6, IL-10 and TNF-α were significantly increased, indicating a more sensitized immune response of frozen cells. Conclusion: Cryopreservation of PBMCs has no effect on the measurement of bioenergetic parameters, although increased apoptotic cells are measured. Cryopreserved PBMCs show an increased immunological response, which must be taken into account when interpreting the results.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.